CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market sale Director sold 2,500 shares at $30.80 ($77,000)
- 4 Open-market sale Director sold 54,962 shares at an average $29.28 ($1,609,321)
- 4 Open-market sale EVP, Strategy & Innovation sold 21,710 shares at an average $30.50 ($662,208)
- 4 Open-market sale EVP, Drug Discovery sold 51,168 shares at an average $30.63 ($1,567,394)
- 4 Open-market buy Chief Medical Officer bought 700 shares at $28.81 ($20,167)
- 4 Exercise or conversion Director acquired 3,086 shares (option exercise)
Page 6 of 19 · 370 filings